Thomas Hodgkin: medical immortal and uncompromising idealist.
作者信息
Stone Marvin J
机构信息
Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, Texas 75246, USA.
出版信息
Proc (Bayl Univ Med Cent). 2005 Oct;18(4):368-75. doi: 10.1080/08998280.2005.11928096.
Abstract
摘要
相似文献
1
Thomas Hodgkin: medical immortal and uncompromising idealist.
Proc (Bayl Univ Med Cent). 2005 Oct;18(4):368-75. doi: 10.1080/08998280.2005.11928096.
2
Idealist thought, social policy and the rediscovery of informal care.
Br J Sociol. 1999 Sep;50(3):467-88.
3
Thomas Hodgkin (1798-1866).
J Med Biogr. 2017 Nov;25(4):222-226. doi: 10.1177/0967772014525100. Epub 2015 Dec 7.
4
Thomas Szasz: The uncompromising rebel and critic of psychiatry.
Psychiatr Pol. 2021 Aug 31;55(4):851-867. doi: 10.12740/PP/125902.
5
The Legacy of Thomas Hodgkin Is Still Relevant 150 Years After His Death. Nothing of Humanity Was Foreign to Him.
Rambam Maimonides Med J. 2017 Jan 30;8(1):e0009. doi: 10.5041/RMMJ.10284.
6
[Thomas Hodgkin and his disease].
Ned Tijdschr Geneeskd. 2012;156(15):A4332.
7
Thomas Hodgkin and Hodgkin's disease. Two paradigms appropriate to medicine today.
JAMA. 1991 Feb 27;265(8):1007-10.
8
Thomas Hodgkin: physician and humanitarian.
Br J Hosp Med (Lond). 2016 Apr;77(4):243. doi: 10.12968/hmed.2016.77.4.243.
9
Thomas hodgkin remembered.
Cancer Treat Rev. 1999 Jun;25(3):133-43. doi: 10.1053/ctrv.1998.0108.
10
The humanitarian and scientific interests of Thomas Hodgkin (1798-1866), discoverer of a disease.
S Afr Med J. 1996 May;86(5):556-8.
引用本文的文献
1
The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers.
Cureus. 2022 Aug 26;14(8):e28421. doi: 10.7759/cureus.28421. eCollection 2022 Aug.
2
Molecular Genetics in Epstein-Barr Virus-Associated Malignancies.
Life (Basel). 2021 Jun 22;11(7):593. doi: 10.3390/life11070593.
3
Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future.
Int J Mol Sci. 2020 Sep 10;21(18):6623. doi: 10.3390/ijms21186623.
4
Multiloculated Cavitary Primary Pulmonary Hodgkin Lymphoma: Case Series.
Case Rep Oncol. 2018 Feb 15;11(1):90-97. doi: 10.1159/000486824. eCollection 2018 Jan-Apr.
5
Apoptotic Effect of on Human Lymphoma U937 Cells.
Pharmacogn Mag. 2017 Oct;13(Suppl 3):S628-S632. doi: 10.4103/pm.pm_93_17. Epub 2017 Oct 11.
6
The Legacy of Thomas Hodgkin Is Still Relevant 150 Years After His Death. Nothing of Humanity Was Foreign to Him.
Rambam Maimonides Med J. 2017 Jan 30;8(1):e0009. doi: 10.5041/RMMJ.10284.
7
Surgery for Non-Hodgkin's Lymphoma.
Oncol Rev. 2015 Jul 3;9(1):274. doi: 10.4081/oncol.2015.274. eCollection 2015 Feb 10.
8
Francis Sibson (1814-1876): the unsung hero of modern surgery and anesthesia.
World J Surg. 2012 Aug;36(8):1993-7. doi: 10.1007/s00268-012-1573-5.
9
Samuel Wilks: the "grand old man" of British medicine.
Proc (Bayl Univ Med Cent). 2010 Jul;23(3):263-5. doi: 10.1080/08998280.2010.11928632.
本文引用的文献
1
Remarks on the Presentation of Microscopical Preparations Made from Some of the Original Tissue Described by Thomas Hodgkin, 1832.
Ann Med Hist. 1926 Winter;8(4):370-374.
2
An Historical Review of Hodgkin's Disease.
Ann Med Hist. 1940 Nov;2(6):471-481.
3
On some Morbid Appearances of the Absorbent Glands and Spleen.
Med Chir Trans. 1832;17:68-114. doi: 10.1177/095952873201700106.
4
Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease.
Hematology Am Soc Hematol Educ Program. 2003:225-47. doi: 10.1182/asheducation-2003.1.225.
5
Polycythaemia vera: Osler-Vaquez disease.
J Med Biogr. 2001 May;9(2):99-103. doi: 10.1177/096777200100900209.
6
The lymphomas.
Semin Hematol. 1999 Oct;36(4 Suppl 7):84-94.
7
Thomas Hodgkin remembered.
Cancer Treat Rev. 1999 Jun;25(3):133-43.
8
The lymphatic contiguity of Hodgkin's disease: a historical study.
Bull N Y Acad Med. 1981 Nov;57(9):776-86.
9
Hodgkin's disease: origin of an eponym--and one that got away.
Bull N Y Acad Med. 1989 Jun;65(5):618-32.
Zotero 插件